Moreover, we found that higher expression of AVL9 was relevant to M status and stages, unfavorable to prognosis in CRC patients, and there is no relationship between AVL9 and other clinicopathological variables such as gender, age, tumor size, differentiation, T classification and N status. Here, AVL9 is linked to colorectal carcinoma.